← Back to Clinical Trials
Recruiting NCT06254924

NCT06254924 Qoyangnuptu: Qoyangnuptu Intervention (QI) App

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06254924
Status Recruiting
Phase
Sponsor Northern Arizona University
Condition Mental Health Wellness 1
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2024-08-30
Primary Completion 2026-10-01

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
QI App UsersParents/Guardians of QI App Users

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2024-08-30 with a primary completion date of 2026-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn about the impacts of using a mobile health app, the Qoyangnuptu Intervention App (QI App) a Southwestern Tribal Community. The main questions it aims to answer are: In American Indian/Alaska Native communities with unique cultural characteristics, how should a youth-focused sociotechnical behavioral health intervention be designed to encourage sustained engagement and positively impact indicators of behavioral health?; How can interactive technical interventions be designed to best support sustained community engagement in a challenged network environment? Participants will: * Receive daily guidance and encouragement to use the app from an anonymous, trained peer mentor * Be able to ask their peer mentors questions in a monitored one-on-one chat in the QI app or in a monitored group chat in the QI app * Log their mood and stress level on the app once per day * Practice mindfulness skills as directed in the QI app, including guided breathing, meditation, drawing, coloring, and walking * Practice Hopi cultural activities like running using the QI app to help track progress towards team mileage goals

Eligibility Criteria

Inclusion Criteria: * 14-25 years old * Belongs to Southwestern Tribal community * Has a smartphone capable of running the QI App * Is able to access the Internet with smartphone at least once per day Exclusion Criteria: * Younger than 14 or older than 25 * Does not belong to Southwestern Tribal Community * Does not have a smartphone capable of running the QI App * Is not able to access the Internet with smartphone at least once per day

Contact & Investigator

Central Contact

Morgan Vigil-Hayes, PhD

✉ morgan.vigil-hayes@nau.edu

📞 9285234863

Principal Investigator

Morgan Vigil-Hayes, PhD

PRINCIPAL INVESTIGATOR

Northern Arizona University

Frequently Asked Questions

Who can join the NCT06254924 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 25 Years, studying Mental Health Wellness 1. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06254924 currently recruiting?

Yes, NCT06254924 is actively recruiting participants. Contact the research team at morgan.vigil-hayes@nau.edu for enrollment information.

Where is the NCT06254924 trial being conducted?

This trial is being conducted at Flagstaff, United States.

Who is sponsoring the NCT06254924 clinical trial?

NCT06254924 is sponsored by Northern Arizona University. The principal investigator is Morgan Vigil-Hayes, PhD at Northern Arizona University. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology